New emerging SARS-CoV-2 variants and antiviral agents
- PMID: 37390619
- PMCID: PMC10292910
- DOI: 10.1016/j.drup.2023.100986
New emerging SARS-CoV-2 variants and antiviral agents
Keywords: Antivirals; Covid-19; Drugs; Sars-cov-2.
Conflict of interest statement
Declaration of Competing Interest The authors declare no competing or financial interests. The authors declare that they have no known competing financial interests or personal relationships that could appear to have influenced the work reported in this paper. The authors declare that the opinions expressed are of a personal nature and do not in any way commit the responsibility of the Administrations to which they belong.
References
-
- Fernandes Q., Inchakalody V.P., Merhi M., Mestiri S., Taib N., Moustafa Abo El-Ella D., Bedhiafi T., Raza A., Al-Zaidan L., Mohsen M.O., Yousuf Al-Nesf M.A., Hssain A.A., Yassine H.M., Bachmann M.F., Uddin S., Dermime S. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann. Med. 2022;54(1):524–540. doi: 10.1080/07853890.2022.2031274. PMID: 35132910; PMCID: PMC8843115. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
